GRCL - Gracell Biotechnologies Inc. (GRCL) CEO Dr. William Cao on Q4 2021 Results - Earnings Call Transcript
Gracell Biotechnologies, Inc. (GRCL) Q4 2021 Results Conference Call March 14, 2022 08:00 AM ET Company Participants Dr. William Cao - Founder, Chairman, and Chief Executive Officer Dr. Martina Sersch - Chief Medical Officer Kevin Xie - Chief Financial Officer Conference Call Participants Joe Catanzaro - Piper Sandler Nick Abbott - Wells Fargo Justin Zelin - BTIG Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the Gracell Biotechnologies Fourth Quarter and Full Year 2021 Conference Call. [Operator Instructions] I will now turn the conference call over to Dr. Kevin Xie, CFO. Please go ahead. Kevin Xie Good morning, and welcome to Gracell's Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast. With me today are Gracell's Founder and Chief Executive Officer, Dr. William Cao; and our Chief Medical Officer, Dr. Martina Sersch. We're excited to discuss our innovative technologies and the breakthrough clinical pipeline
For further details see:
Gracell Biotechnologies, Inc. (GRCL) CEO Dr. William Cao on Q4 2021 Results - Earnings Call Transcript